African Journal of Reproductive Health, published by the WOMENS HEALTH & ACTION RESEARCH CENTRE, is a vital resource for researchers and practitioners in the fields of obstetrics, gynecology, and reproductive health. This journal, with ISSN 1118-4841 and E-ISSN 2141-3606, has been contributing to the academic discourse since its inception in 1997, offering insightful research and evidence-based articles that address pressing reproductive health issues in Africa and beyond. With a Q3 category ranking in essential areas such as Obstetrics and Gynecology, Public Health, and Reproductive Medicine, the journal is positioned in the 34th to 30th percentile among its peers, reflecting its commitment to high-quality scholarship. Despite its classification as a non-open access journal, the publication remains accessible to a diverse audience, fostering knowledge exchange in reproductive health. The African Journal of Reproductive Health serves as a crucial platform for emerging and established researchers to disseminate their findings, enhancing the understanding of reproductive health challenges and solutions in the African context.

Sexual & Reproductive Healthcare, published by Elsevier Ireland Ltd, is a premier academic journal dedicated to advancing knowledge and best practices in the fields of Maternity and Midwifery, as well as Obstetrics and Gynecology. With a strong emphasis on evidence-based research, this journal, ISSN: 1877-5756 and E-ISSN: 1877-5764, holds a notable Q1 ranking in Maternity and Midwifery, and a Q2 ranking in Obstetrics and Gynecology, marking it as a leader in its categories. As of 2023, it is ranked #9 among 43 journals in Nursing - Maternity and Midwifery and #104 among 209 in Medicine - Obstetrics and Gynecology, reinforcing its importance to researchers and practitioners globally. The journal is committed to publishing high-quality articles that address critical issues in sexual and reproductive health, fostering an academic community that drives innovation and supports clinical excellence. Located in the Netherlands, Sexual & Reproductive Healthcare is accessible to a wide audience of researchers, healthcare professionals, and students, facilitating a comprehensive understanding of the complexities involved in reproductive health and enhancing patient care practices.

The International Journal of Sexual Health, published by Routledge Journals, Taylor & Francis Ltd, serves as a crucial platform for the dissemination of cutting-edge research in the multifaceted field of sexual health. With an ISSN of 1931-7611 and an E-ISSN of 1931-762X, this journal has rapidly established itself as a key publication since its inception in 2007, boasting an impressive trajectory leading to its anticipated convergence into 2024. The journal excels in various domains, achieving a Q1 ranking in Gender Studies and securing Q2 placements in Dermatology, Public Health, Environmental and Occupational Health, Reproductive Medicine, and Social Psychology for 2023, reflecting its broad interdisciplinary influence. Furthermore, the Scopus rankings position it favorably within its respective categories, confirming its relevance and academic rigor. Although the journal operates under a subscription model, it remains dedicated to illuminating pressing issues in sexual health, making it indispensable for researchers, professionals, and students dedicated to advancing knowledge in this essential area of study.

Welcome to the European Journal of Obstetrics & Gynecology and Reproductive Biology, a premier publication dedicated to advancing the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier, this journal has been a vital resource since its inception in 1971, continuing to provide high-quality, peer-reviewed research through 2024 and beyond. With an impressive impact factor and recognized in the Q2 quartile for both obstetrics and gynecology, as well as reproductive medicine, it ranks among the top journals in its field, being positioned at #59 out of 209 in Obstetrics and Gynecology and #29 out of 90 in Reproductive Medicine. Though not currently an Open Access journal, it remains committed to disseminating valuable findings to enhance clinical practice and facilitate further research. Researchers, professionals, and students can expect insightful articles, comprehensive reviews, and pioneering studies that significantly impact women's health and reproductive biology.

Frontiers in Reproductive Health is a leading open-access journal published by Frontiers Media SA in Switzerland, dedicated to advancing the field of reproductive health through high-quality research and comprehensive reviews. With a commitment to fostering an interdisciplinary dialogue, this journal covers an array of topics including epidemiology, family practice, obstetrics and gynecology, and reproductive medicine. As of 2023, it ranks in the Q3 quartile in Epidemiology, Q1 in Family Practice, and Q2 in both Obstetrics and Gynecology and Reproductive Medicine, reflecting its significance and growing influence in these areas. Researchers and professionals can benefit from the journal's wide distribution and open access policy, which facilitates the sharing of knowledge and enhances the visibility of their work. By embracing innovative studies and harnessing the talents of both established scholars and emerging voices, Frontiers in Reproductive Health plays a crucial role in shaping the future of reproductive health research and practice.

WOMEN'S HEALTH ISSUES, published by Elsevier Science Inc, stands as a premier journal within the realm of women’s health research, offering a vital platform for the dissemination of cutting-edge studies. As an influential publication with an impressive reputation, it encompasses critical areas such as social sciences, maternity and midwifery, obstetrics and gynecology, and public health. With a remarkable Q1 ranking across various categories in 2023, including Nursing, Maternity and Midwifery and Obstetrics and Gynecology, this journal is recognized for its substantial impact on advancing knowledge in women's health issues. Researchers and healthcare professionals will find valuable insights and empirical studies that inform practice and policy. Although the journal is not Open Access, it provides a wealth of information originating from rigorous research and expert reviews aimed at enhancing women’s health outcomes. To explore a comprehensive range of topics, this journal spans a convergence period from 1990 to 2024, continually evolving with the field's advancements.

Contraception and Reproductive Medicine is a prestigious open-access journal published by BMC that has been serving the global community since 2016. With a focus on the latest research and advancements in the fields of contraception and reproductive health, this journal aims to address the challenges and innovations in fertility management, women's health, and sexual education. As an Open Access platform, it provides researchers, professionals, and students unrestricted access to high-quality, peer-reviewed articles, facilitating the dissemination of vital knowledge and findings. Although specific metrics like the impact factor and H-index are unavailable, the journal's commitment to fostering a vibrant academic dialogue ensures it remains an influential resource in reproductive medicine. Located in London, England, Contraception and Reproductive Medicine invites contributions that highlight both clinical practices and policy implications, ultimately aiming to improve reproductive health care worldwide.

The Journal of Pediatric and Adolescent Gynecology, published by Elsevier Science Inc, serves as a crucial platform for researchers and practitioners in the fields of pediatrics, obstetrics, and gynecology. With an ISSN of 1083-3188 and an E-ISSN of 1873-4332, this esteemed journal has been disseminating knowledge since 1996, with contributions expected to continue through 2024. Positioned in the Q2 category across multiple specialties including Medicine (miscellaneous), Obstetrics and Gynecology, and Pediatrics, Perinatology and Child Health, it caters to a growing need for scholarly discourse in the health care of young females. The journal maintains a strong impact factor and ranks notably in its category on Scopus, with a significant percentile indicating its influence and relevance within the academic community. Although it does not currently operate as an open-access journal, it offers vital insights and research findings that are essential for shaping practice and advancing knowledge in this specialized area. Engaging with this journal not only aids in staying abreast of the latest developments but also fosters collaboration and innovation in pediatric and adolescent health care.

BJOG - An International Journal of Obstetrics and Gynaecology is a leading peer-reviewed journal in the field of obstetrics and gynecology, published by Wiley in the United Kingdom. With a rich history dating back to 1902, this esteemed journal is recognized for its significant contribution to advancing clinical practice and research, consistently ranking in the top tier (Q1) of its category, according to the 2023 Scopus rankings. Representing the best of 209 journals in the discipline, BJOG is dedicated to publishing high-quality research and innovative insights that address critical issues in women's health. While not an open-access journal, it provides valuable access options for institutions and individuals to stay informed about the latest developments and evidence-based practices. The journal's commitment to disseminating cutting-edge research makes it an essential resource for clinicians, researchers, and academics aiming to improve health outcomes in obstetrics and gynecology.

CONTRACEPTION is a leading academic journal dedicated to advancing the field of reproductive health, published by Elsevier Science Inc. Since its inception in 1970, the journal has consistently provided a platform for high-quality research and insights in both Obstetrics and Gynecology and Reproductive Medicine, achieving notable recognition as a Q1 journal in these categories as of 2023. With an impact factor that underscores its significance—ranked #57 out of 209 in Obstetrics and Gynecology and #28 out of 90 in Reproductive Medicine according to Scopus—CONTRACEPTION is essential reading for researchers, clinicians, and students alike. The journal is committed to publishing innovative studies, review articles, and evidence-based guidelines that inform clinical practice and enhance patient care. Although it does not currently offer open access options, its comprehensive coverage of contemporary issues and empirical data makes it an invaluable resource for those invested in the future of reproductive healthcare.